전체메뉴 닫기

항상 최고의 진료를
약속합니다

외과(유방센터) 조영업 초빙교수

일반진료
오전 진료 진료 진료 4주
오후 진료 진료

전문분야

유방암, 유방양성질환

교수 경력

  • 연세대학교
  • 인하대학교

진료 경력

  • 인하대학교의과대학부속병원여성암센터 소장
  • 연세대학교 의과대학 세브란스병원 유방외과 과장
  • 연세대학교 의과대학 세브란스병원 연세암병원 유방암센터장
  • 차의과학대학교 일산차병원 유방센터

학회·연구·연수·수상 경력

  • 미국 서던캘리포니아대학교 노리스 암센터 교환 교수
  • 대한림프부종학회 부회장
  • 한국유방암학회 부회장
  • 대한외과학회 기획이사 역임
  • 한국유방암학회 경인지회 회장, 정보이사, 법제이사 역임
  • 대한종양외과학회 감사 역임
  • 보건복지부 장관 표창

  • 언론기사·영상
  • 논문
  1. Assessment of the Prognostic Staging System of American Joint Committee on Cancer 8th Edition for Breast Cancer: Comparisons with the Conventional Anatomic Staging System. J Breast Cancer. 2020 Jan 9;23(1):59-68. doi: 10.4048/jbc.2020.23.e9. eCollection 2020 Feb. PubMed PMID: 32140270; PubMed Central PMCID: PMC7043951.
  2. Coping style at diagnosis and its association with subsequent health-related quality of life in women with breast cancer: A 3-year follow-up study. Eur J Oncol Nurs. 2020 Apr;45:101726. doi: 10.1016/j.ejon.2020.101726. Epub 2020 Feb 7. PubMed PMID: 32155584.
  3. Design of a randomized controlled trial of a partnership-based, needs-tailored self-management support intervention for post-treatment breast cancer survivors. BMC Cancer. 2020 May 1;20(1):367. doi: 10.1186/s12885-020-06861-x. PubMed PMID:32357926.
  4. Pre-post analysis of a social capital-based exercise adherence intervention for breast cancer survivors with moderate fatigue: a randomized controlled trial. Support Care Cancer. 2020 Feb 26.
  5. Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older. Breast Cancer Res Treat. 2020 Feb;179(3):687-697
  6. Optimal treatment of pseudoangiomatous stromal hyperplasia of the breast. Asian J Surg. 2019 Oct 26
  7. Robot-assisted Nipple-sparing Mastectomy with Immediate Breast Reconstruction: An Initial Experience. Sci Rep. 2019 Oct 30;9(1):15669.
  8. An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast. Yonsei Med J. 2019 Nov;60(11):1028-1035
  9. Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26-30. Breast Cancer Res. 2019 Oct 16;21(1):110
  10. Is the frozen section examination for sentinel lymph node necessary in early breast cancer patients? Ann Surg Treat Res. 2019 Aug;97(2):49-57
  11. Risk of Lymphedema Following Contemporary Treatment for Breast Cancer: An Analysis of 7617 Consecutive Patients From a Multidisciplinary Perspective. Ann Surg. 2019 Jul 23
  12. Development of an exercise adherence program for breast cancer survivors with cancer-related fatigue-an intervention mapping approach. Support Care Cancer. 2019 Dec;27(12):4745-4752.
  13. Changes in Bone Mineral Density in Women With Breast Cancer: A Prospective Cohort Study. Cancer Nurs. 2019 Mar/Apr;42(2):164-172.
  14. Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort. Breast Cancer Res Treat. 2019 May;175(1):203-215.
  15. Prevalence of breast cancer-related risk factors in underweight premenopausal women: the Korea National Health and Nutrition Examination Survey IV-VI. Breast Cancer Res Treat. 2019 Apr;174(2):515-524.
  16. BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts. Sci Rep. 2018 Oct 15;8(1):15263. 31859-8.
  17. Gasless Robot-Assisted Nipple-Sparing Mastectomy: A Case Report. J Breast Cancer. 2018 Sep;21(3):334-338.
  18. A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide. Cancer Res Treat. 2019 Apr;51(2):812-818.
  19. External validation of IBTR! 2.0 nomogram for prediction of ipsilateral breast tumor recurrence. Radiat Oncol J. 2018 Jun;36(2):139-146.
  20. Assessment of Quality of Life and Safety in Postmenopausal Breast Cancer Patients Receiving Letrozole as an Early Adjuvant Treatment. J Breast Cancer. 2018 Jun;21(2):182-189.
  21. Association between Changes in Serum 25-Hydroxyvitamin D Levels and Survival in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy. J Breast Cancer. 2018 Jun;21(2):134-141.
  22. Impact of Micrometastatic Axillary Nodes on Survival of Breast Cancer Patients with Tumors ≤2 cm. World J Surg. 2018 Dec;42(12):3969-3978
  23. A hierarchical prognostic model for risk stratification in patients with early breast cancer according to (18) F-fludeoxyglucose uptake and clinicopathological parameters. Cancer Med. 2018 Apr;7(4):1127-1134.
  24. Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients. Cancer Res Treat. 2018 Jul;50(3):801-812.
  25. Conserving the Lymphatic Drainage of the Arm Using Axillary Reverse Mapping Procedure in Breast Cancer Patients. Clinical Lymphology and Lymphedema. 2017 May ;2(1):6-9